What is KLOW? A quad-peptide research blend
KLOW combines four of the most extensively studied research peptides in skin, collagen and repair biology into a single co-lyophilised vial: KPV (the C-terminal α-MSH tripeptide) for NF-κB suppression research, GHK-Cu for collagen and elastin synthesis, BPC-157 for angiogenesis and tissue integrity, and TB-500 for actin regulation and systemic repair. The blend is engineered for research groups running combined-pathway protocols where reconstituting four separate vials would introduce handling variance.



